Identity
- Trade Name
- BÜHLMANN fCAL® turbo Reagent Kit FDA UDI
- Generic Name
- Calprotectin IVD, reagent FDA UDI
- Device Name
- Reagent kit for quantitative PETIA assay for the determination of calprotectin (MRP8/14) in human stool specimens FDA UDI
- Model / Reference
- B-KCAL-RSET FDA UDI
- Description
- Reagent kit for quantitative PETIA assay for the determination of calprotectin (MRP8/14) in human stool specimens FDA UDI
Identifiers
- Primary DI / UDI-DI
- EBUHBKCALRSET0 FDA UDI
- FDA Product Code
- NXO FDA UDI
- GMDN Term
- Calprotectin IVD, reagent FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 866.5180 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Calprotectin IVD, reagent
BÜHLMANN fCAL® turbo Reagent Kit by Bühlmann Laboratories AG — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Calprotectin IVD, reagent.
- LIAISON Q.S.E.T. Device Plus — Diasorin Inc. · Class II
- fCAL turbo — Bühlmann Laboratories AG · Class II
- BÜHLMANN fCAL® turbo Reagent Kit — Bühlmann Laboratories AG · Class II
- fCAL turbo — Bühlmann Laboratories AG
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bühlmann Laboratories AG
Sources (1)
- FDA UDI b5a0a8a0-52bd-4b22-af2d-be1678c15f01 35 fields · synced May 30, 2026